Autoantibodies to Endothelial Cell Surface ATP Synthase, the Endogenous Receptor for Hsp60, Might Play a Pathogenic Role in Vasculitides
2011

Autoantibodies to ATP Synthase and Their Role in Vasculitis

Sample size: 64 publication 10 minutes Evidence: moderate

Author Information

Author(s): Alard Jean-Eric, Hillion Sophie, Guillevin Loïc, Saraux Alain, Pers Jacques-Olivier, Youinou Pierre, Jamin Christophe

Primary Institution: Université de Brest and Université Européenne de Bretagne, Brest, France

Hypothesis

The study investigates the interaction between heat shock protein 60 (hsp60) and ATP synthase on endothelial cells and the presence of anti-ATP synthase antibodies in patients with vasculitides.

Conclusion

The study concludes that ATP synthase is targeted by autoantibodies in vasculitides, leading to intracellular acidification, which can be modulated by hsp60 binding.

Supporting Evidence

  • Hsp60 binds to the β-subunit of ATP synthase on endothelial cells.
  • Higher frequencies of anti-ATP synthase antibodies were found in patients with primary vasculitides compared to those with secondary vasculitides.
  • Anti-ATP synthase antibodies can induce intracellular acidification in endothelial cells.

Takeaway

Some people have antibodies that attack a protein on blood vessel cells, which can make those cells sick, but a helper protein can protect them.

Methodology

The study used Far Western blotting, co-immunoprecipitation, and enzyme-linked immunosorbent assay (ELISA) to analyze the interactions and antibody presence.

Potential Biases

Potential bias in patient selection and the interpretation of antibody reactivity.

Limitations

The study does not explore the long-term effects of these antibodies or the specific mechanisms of their pathogenicity in detail.

Participant Demographics

Participants included 22 patients with Wegener's granulomatosis, 14 with Churg-Strauss syndrome, 6 with polyarteritis nodosa, and 10 with microscopic polyangiitis, as well as 64 patients with systemic lupus erythematosus, 18 with primary Sjögren's syndrome, and 20 with rheumatoid arthritis.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0014654

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication